Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intravenous theophylline?

G Szymaniak, T J Anderer

    Hospital Pharmacy
    |November 7, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Aminophylline, a bronchodilator for asthma and COPD, is seeing decreased use due to newer theophylline formulations. This review examines the potential utility of premixed intravenous theophylline.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Patient anonymity precludes pharmaceutical care.

    American journal of hospital pharmacy·1993
    Same author

    Isoniazid and rhabdomyolysis.

    Annals of internal medicine·1989
    Same author

    Isoproterenol dose for nebulization.

    The Journal of pediatrics·1982
    See all related articles

    Area of Science:

    • Pharmacology
    • Respiratory Medicine
    • Clinical Pharmacy

    Background:

    • Aminophylline (theophylline ethylenediamine) has a history of use as a bronchodilator in asthma and COPD.
    • Its oral use has decreased with the advent of anhydrous theophylline preparations.
    • Intravenous aminophylline usage may be impacted by new premixed theophylline products.

    Purpose of the Study:

    • To review the potential usefulness of premixed intravenous theophylline.
    • To assess the impact of new formulations on aminophylline's clinical role.

    Main Methods:

    • Literature review of aminophylline and intravenous theophylline products.
    • Analysis of clinical guidelines and pharmacological data.

    Main Results:

    Related Experiment Videos

    • New anhydrous theophylline formulations offer alternatives to aminophylline.
    • Premixed intravenous theophylline presents a convenient option, potentially reducing reliance on aminophylline.

    Conclusions:

    • Premixed intravenous theophylline may offer advantages in administration and potentially reduce aminophylline use.
    • Further research may be needed to fully establish the role of premixed intravenous theophylline in respiratory care.